Rajkamal Srivastava is a postdoctoral researcher in Cammie Lesser’s group at Tufts Medical Center. In this Postdoc Portrait, ...

During a cabinet meeting at the White House last month, Donald Trump raved about reducing drug prices by more than 100%, which is infeasible unless he plans on forcing drug companies to pay customers ...

In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases, oncology, and preventive vaccines. A recent article ...

If you’ve ever looked at your blood pressure numbers and wondered, “What does that actually mean?”, you’re not alone. High blood pressure affects millions of Americans, and many don’t even realize ...

After reportedly flirting with going public for years, the artificial intelligence-powered drug developer Insilico Medicine has laid out plans to raise about $292 million through a listing on the ...

Inside a lab at the Massachusetts Institute of Technology late last year, scientists gave an AI system a new task: designing entirely new molecules for potential antibiotics from scratch. Within a day ...

This repository offers a comprehensive collection of official resources, detailed guides, and reference materials for Substance Designer on Windows PCs. It supports users with tutorials, best ...

BARCELONA, Spain — An experimental drug that takes a novel approach to protecting injured brain cells has shown promising results in an early Phase 2 trial of patients with acute ischemic stroke (AIS) ...

An MIT team used artificial intelligence to design novel antibiotics, two of which showed promise against MRSA and gonorrhea. With help from artificial intelligence, MIT researchers have designed ...

Dianthus Therapeutics and Boehringer Ingelheim headlined the latest round of licensing deals featuring Chinese biotechs. Fierce's deep dive into the dispute between Novo Nordisk and KBP Biosciences ...